Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Immuneering (IMRX) over the last 5 years, with Dec 2024 value amounting to $328,377.

  • Immuneering's Amortizatization of Intangibles fell 79.88% to $81,212 in Q4 2024 from the same period last year, while for Dec 2024 it was $257,485, marking a year-over-year decrease of 57.46%. This contributed to the annual value of $328,377 for FY2024, which is 67.73% down from last year.
  • Per Immuneering's latest filing, its Amortizatization of Intangibles stood at $328,377 for FY2024, which was down 67.73% from $1.0 million recorded in FY2023.
  • In the past 5 years, Immuneering's Amortizatization of Intangibles ranged from a high of $1.0 million in FY2023 and a low of -$130,240 during FY2021.
  • In the last 3 years, Immuneering's Amortizatization of Intangibles had a median value of $519,541 in 2022 and averaged $621,834.
  • In the last 5 years, Immuneering's Amortizatization of Intangibles slumped by 336.90% in 2021 and then skyrocketed by 498.91% in 2022.
  • Over the past 5 years, Immuneering's Amortizatization of Intangibles (Yearly) stood at $54,977 in 2020, then crashed by 336.90% to -$130,240 in 2021, then soared by 498.91% to $519,541 in 2022, then surged by 95.86% to $1.0 million in 2023, then crashed by 67.73% to $328,377 in 2024.